The effect of dental and periodontal treatment on blood sugar control in children and teenagers with type 1 diabetes
| ISRCTN | ISRCTN21311491 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN21311491 |
| Sponsor | King Abdullah Bin Abdulaziz University Hospital |
| Funder | Investigator initiated and funded |
- Submission date
- 29/09/2026
- Registration date
- 06/10/2026
- Last edited
- 06/10/2026
- Recruitment status
- Recruiting
- Overall study status
- Ongoing
- Condition category
- Oral Health
Plain English summary of protocol
Background and study aims
Type 1 diabetes is a long-term condition that affects blood sugar control and requires ongoing treatment. Children and young people with type 1 diabetes are at increased risk of dental and gum disease. Research in adults suggests that improving oral health may help improve blood sugar control, but this has not been adequately studied in children and adolescents. This study aims to assess whether dental and periodontal treatment can improve glycaemic control and oral health outcomes in children and young people with type 1 diabetes.
Who can participate?
Children and young people aged 6 to 18 years with type 1 diabetes and evidence of dental caries and/or periodontal disease.
What does the study involve?
Participants are randomly allocated to either an immediate-treatment group or a delayed-treatment group. Those in the immediate-treatment group receive dental and periodontal treatment shortly after enrolment, while those in the delayed-treatment group receive the same treatment after a 3-month waiting period. Treatment may include preventive advice, professional cleaning, restorative dental care and other routine dental procedures as required. Researchers assess oral health and blood sugar control at baseline and follow-up visits. The study includes an internal pilot phase to assess recruitment, retention and treatment delivery before progressing to the main trial.
What are the possible benefits and risks of participating?
Participants may benefit from improved oral health and may also experience improvements in blood sugar control. The information gained may help improve future care for children and young people with type 1 diabetes. Risks are expected to be similar to those associated with routine dental treatment and may include temporary discomfort during examinations or treatment procedures.
Where is the study run from?
The study is coordinated by King Saud University, Riyadh, Saudi Arabia, and is being conducted at study sites in Saudi Arabia.
When is the study starting and how long is it expected to run for?
May 2025. Recruitment is expected to continue until 31 December 2027, and the overall study completion date is 30 April 2028.
Who is funding the study?
The study is investigator initiated and funded.
Who is the main contact?
Dr Ahlam Alotaibi, King Saud University, Saudi Arabia, aalotaibi38@ksu.edu.sa
Contact information
Principal investigator, Scientific, Public
King Saud University, University Road
Riyadh
11591
Saudi Arabia
| Phone | +966114670000 |
|---|---|
| aalotaibi38@ksu.edu.sa |
Study information
| Primary study design | Interventional |
|---|---|
| Allocation | Randomized controlled trial |
| Masking | Blinded (masking used) |
| Control | Active |
| Assignment | Parallel |
| Purpose | Treatment |
| Scientific title | The effect of dental/periodontal treatment on glycemic control in children and adolescents with type 1 diabetes mellitus: a randomized controlled trial with an internal vanguard (pilot) phase |
| Study objectives | To determine whether dental/periodontal treatment improves glycemic control (HbA1c and time in target glucose range) in children and adolescents with type 1 diabetes mellitus (T1DM) and coexisting dental or periodontal disease, compared with delayed treatment. The trial began with an internal vanguard (pilot) phase to establish operational feasibility (recruitment, retention, and intervention-delivery rates ≥80%) before proceeding to full-scale, multicenter enrollment. |
| Ethics approval(s) |
Approved 11/12/2023, King Abdullah bin Abdulaziz University Hospital IRB Committee (Airport Road, Riyadh, 11671, with a P.O. Box of 84428, Saudi Arabia; +966118220000; irb@kaauh.edu.sa), ref: HA-01-R-104 |
| Health condition(s) or problem(s) studied | Type 1 diabetes mellitus with coexisting dental caries, gingivitis, or chronic apical periodontitis, in children and adolescents |
| Intervention | Intervention arm: dental/periodontal treatment (preventive, restorative, and radiological assessments as clinically indicated) at the pediatric dental clinic, standardized treatment plan, expected completion within 1 month. Comparator arm: delayed treatment (wait-list control) — participants wait 3 months, then receive the same standardized treatment as the intervention arm. Randomization: 1:1, blocked and stratified by baseline HbA1c (<7%, 7–9%, >9%), allocation generated via REDCap. Follow-up: participants assessed at baseline and again 3 months after finishing their respective treatment period. |
| Intervention type | Other |
| Primary outcome measure(s) |
|
| Key secondary outcome measure(s) |
|
| Completion date | 30/04/2028 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Mixed |
| Lower age limit | 6 Years |
| Upper age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 186 |
| Total final enrolment | 20 |
| Key inclusion criteria | 1. Confirmed diagnosis of type 1 diabetes mellitus 2. Age 6–18 years 3. Diagnosis of relevant dental or periodontal disease (dental caries, gingivitis, or chronic apical periodontitis) |
| Key exclusion criteria | 1. Systemic inflammatory disease 2. Congenital or genetic dental abnormalities 3. Ongoing orthodontic treatment 4. Chronic use of corticosteroids or antibiotics |
| Date of first enrolment | 01/05/2025 |
| Date of final enrolment | 31/12/2027 |
Locations
Countries of recruitment
- Saudi Arabia
Study participating centres
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan | Individual participant data underlying the results will be made available on reasonable request to the corresponding author (Ahlam Alotaibi, aalotaibi38@ksu.edu.sa), following publication, for the purpose of academic collaboration or meta-analysis, subject to institutional and ethics committee approval. |
Editorial Notes
05/10/2026: Study’s existence confirmed by the King Abdullah Bin Abdulaziz University Hospital Ethics Committee, Saudi Arabia.